Indivior Pharmaceuticals, Inc. (INDV)
35.71
+0.33
(+0.93%)
USD |
NASDAQ |
Oct 02, 16:00
35.35
-0.36
(-1.01%)
After-Hours: 20:00
Indivior Pharmaceuticals Price : 35.71 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 35.46 | 36.15 | 35.26 | 35.71 | 1.669M |
| Oct 01, 2026 | 35.85 | 36.20 | 35.25 | 35.38 | 1.879M |
| Sep 30, 2026 | 36.54 | 36.60 | 35.79 | 35.85 | 1.674M |
| Sep 29, 2026 | 36.74 | 37.05 | 36.08 | 36.59 | 2.005M |
| Sep 28, 2026 | 35.50 | 36.96 | 35.43 | 36.88 | 1.173M |
| Sep 25, 2026 | 35.90 | 36.22 | 35.72 | 35.82 | 1.098M |
| Sep 24, 2026 | 35.71 | 36.28 | 35.57 | 36.00 | 2.222M |
| Sep 23, 2026 | 36.23 | 36.90 | 35.78 | 35.91 | 1.058M |
| Sep 22, 2026 | 35.53 | 36.63 | 35.48 | 36.19 | 2.216M |
| Sep 21, 2026 | 35.00 | 35.63 | 34.77 | 35.53 | 1.299M |
| Sep 18, 2026 | 35.59 | 35.62 | 34.59 | 34.88 | 4.684M |
| Sep 17, 2026 | 34.76 | 35.90 | 34.47 | 35.69 | 2.691M |
| Sep 16, 2026 | 33.97 | 34.54 | 33.84 | 34.35 | 1.866M |
| Sep 15, 2026 | 34.59 | 34.59 | 33.74 | 34.22 | 2.701M |
| Sep 14, 2026 | 34.74 | 35.01 | 34.15 | 34.47 | 3.429M |
| Sep 11, 2026 | 34.49 | 34.83 | 34.23 | 34.49 | 1.297M |
| Sep 10, 2026 | 34.58 | 34.87 | 34.04 | 34.51 | 1.320M |
| Sep 09, 2026 | 34.32 | 34.80 | 33.92 | 34.77 | 1.352M |
| Sep 08, 2026 | 34.35 | 34.84 | 33.84 | 34.32 | 1.824M |
| Sep 04, 2026 | 34.74 | 35.31 | 34.55 | 34.94 | 1.019M |
| Sep 03, 2026 | 35.18 | 35.23 | 34.57 | 34.83 | 1.826M |
| Sep 02, 2026 | 34.74 | 35.28 | 34.68 | 35.05 | 2.975M |
| Sep 01, 2026 | 35.00 | 35.44 | 34.50 | 34.56 | 2.095M |
| Aug 31, 2026 | 34.87 | 35.30 | 34.33 | 34.93 | 1.963M |
| Aug 28, 2026 | 35.31 | 35.49 | 34.49 | 34.87 | 3.309M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Supernus Pharmaceuticals, Inc. | 42.38 |
| Eli Lilly & Co. | 1142.85 |
| Bristol Myers Squibb Co. | 61.15 |
| Liquidia Corp. | 28.64 |
| Harmony Biosciences Holdings, Inc. | 39.64 |
Price Related Metrics
| PE Ratio | 12.68 |
| PS Ratio | 3.398 |
| PEG Ratio | 0.0551 |
| Earnings Yield | 7.88% |
| Market Cap | 4.214B |
| Operating PE Ratio | 8.508 |
| Normalized PE Ratio | 10.01 |